F. Fang

发表

Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.

Di Chen, Yuxin Shen, Huojun Zhang, 2017, Molecular medicine reports.

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.

R. Paridaens, J. Wanders, M. Campone, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

C. Takimoto, S. Mani, M. Mita, 2009, Clinical Cancer Research.

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors Cancer Therapy: Clinical

Y. Wong, A. Tan, L. Rosen, 2022 .

Exploration into the Clinical Value of Breast-Conserving Therapy Combined with Sentinel Lymph Node Biopsy in the Treatment of Early Breast Cancer

F. Fang, L. Gu, GU Lin, 2021, Indian Journal of Pharmaceutical Sciences.

ERA 223: A phase 3 trial of radium-223 dichloride (Ra-223) in combination with abiraterone acetate (abiraterone) and prednisone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone predominant metastatic castration-resistant prostate cancer (mCRPC).

F. Saad, C. Parker, K. Miller, 2015 .

Phase II study of eribulin mesylate (E7389) halichondrin b analog in patients with refractory breast cancer

C. Fabian, J. Blum, L. Vahdat, 2007 .

Phase II study of eribulin mesylate (E7389) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracycline, taxane, and capecitabine therapy

J. Wanders, M. Campone, C. Twelves, 2008 .

A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.

P. Li, X. Yang, F. Fang, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

An observational study of apatinib mesylate in treating advanced non-small cell lung cancer with unknown driving gene(s).

Yifeng Wang, F. Fang, Wen-guang Song, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2019, International journal of radiation oncology, biology, physics.

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

David A. Smith, A. Tan, C. Fabian, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score).

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.

Sten Nilsson, Oliver Sartor, John Logue, 2014, The Lancet. Oncology.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial.

Yoon-Koo Kang, Jianming Xu, Jun Suk Kim, 2012, European journal of cancer.

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer medicine.

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis

Zhen Jia, Yuxin Shen, Huojun Zhang, 2019, Front. Oncol..

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2016, BMJ Open.

Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2017, Cancer medicine.

Pain analyses from the phase III randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases.

C. Parker, S. Nilsson, Ø. Bruland, 2013 .

Pain analysis from the phase III randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) with bone metastases.

C. Parker, O. Bruland, A. Sartor, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer

Qiang-hua Zhou, Min Xu, F. Fang, 2023, Frontiers in Endocrinology.

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications

Di Chen, Xianzhi Zhao, Yuxin Shen, 2020, Cancer Biology and Medicine.

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

Yuxin Shen, Huojun Zhang, Hongliang Xie, 2021, Frontiers in Oncology.

Correlation between baseline variables and survival in the radium-223 dichloride (Ra-223) phase III ALSYMPCA trial with attention to total ALP changes.

C. Parker, S. Wilhelm, M. Shan, 2013 .

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Huojun Zhang, Xiaofei Zhu, F. Fang, 2023, Radiation Oncology.

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Y. Wong, A. Tan, L. Rosen, 2009, Clinical Cancer Research.